208 related articles for article (PubMed ID: 1891289)
21. Mass vaccination of children with pertussis toxoid--decreased incidence in both vaccinated and nonvaccinated persons.
Taranger J; Trollfors B; Bergfors E; Knutsson N; Sundh V; Lagergård T; Lind-Brandberg L; Zackrisson G; White J; Cicirello H; Fusco J; Robbins JB
Clin Infect Dis; 2001 Oct; 33(7):1004-10. PubMed ID: 11528572
[TBL] [Abstract][Full Text] [Related]
22. Pertussis epidemic despite high levels of vaccination coverage with acellular pertussis vaccine.
Sala-Farré MR; Arias-Varela C; Recasens-Recasens A; Simó-Sanahuja M; Muñoz-Almagro C; Pérez-Jové J
Enferm Infecc Microbiol Clin; 2015 Jan; 33(1):27-31. PubMed ID: 24216286
[TBL] [Abstract][Full Text] [Related]
23. Pertussis epidemic in Oklahoma. Difficulties in preventing transmission.
Nkowane BM; Wassilak SG; McKee PA; O'Mara DJ; Dellaportas G; Istre GR; Orenstein WA; Bart KJ
Am J Dis Child; 1986 May; 140(5):433-7. PubMed ID: 3962936
[TBL] [Abstract][Full Text] [Related]
24. Impact of a pertussis epidemic on infant vaccination in Washington state.
Wolf ER; Opel D; DeHart MP; Warren J; Rowhani-Rahbar A
Pediatrics; 2014 Sep; 134(3):456-64. PubMed ID: 25136046
[TBL] [Abstract][Full Text] [Related]
25. Boostrix: a reduced-dose acellular pertussis vaccine for use in adolescents and adults.
Li WC; Wu TZ; Huang YC; Huang LM
Expert Rev Vaccines; 2009 Oct; 8(10):1317-27. PubMed ID: 19803753
[TBL] [Abstract][Full Text] [Related]
26. Effects of a minimum interval immunization schedule for diphtheria and tetanus toxoids and acellular pertussis vaccination during a pertussis outbreak.
Bronson-Lowe D; Anderson SM
Arch Pediatr Adolesc Med; 2009 May; 163(5):417-21. PubMed ID: 19414686
[TBL] [Abstract][Full Text] [Related]
27. Prevention of pertussis, tetanus, and diphtheria among pregnant and postpartum women and their infants recommendations of the Advisory Committee on Immunization Practices (ACIP).
Murphy TV; Slade BA; Broder KR; Kretsinger K; Tiwari T; Joyce PM; Iskander JK; Brown K; Moran JS;
MMWR Recomm Rep; 2008 May; 57(RR-4):1-51. PubMed ID: 18509304
[TBL] [Abstract][Full Text] [Related]
28. Experience with diphtheria toxoid-tetanus toxoid-acellular pertussis vaccine in Japan.
Sato H; Sato Y
Clin Infect Dis; 1999 Jun; 28 Suppl 2():S124-30. PubMed ID: 10447030
[TBL] [Abstract][Full Text] [Related]
29. Epidemiology of pertussis.
Black S
Pediatr Infect Dis J; 1997 Apr; 16(4 Suppl):S85-9. PubMed ID: 9109162
[TBL] [Abstract][Full Text] [Related]
30. [Immunization of adolescents and adults as the strategy of improvement of epidemiology of pertussis].
Lutyńska A; Wiatrzyk A; Mosiej E; Zawadka M
Przegl Epidemiol; 2011; 65(1):45-50. PubMed ID: 21735835
[TBL] [Abstract][Full Text] [Related]
31. Resurgence of pertussis at the age of vaccination: clinical, epidemiological, and molecular aspects.
Torres RS; Santos TZ; Torres RA; Pereira VV; Fávero LA; M Filho OR; Penkal ML; Araujo LS
J Pediatr (Rio J); 2015; 91(4):333-8. PubMed ID: 25623040
[TBL] [Abstract][Full Text] [Related]
32. Protective efficacy of the Takeda acellular pertussis vaccine combined with diphtheria and tetanus toxoids following household exposure of Japanese children.
Mortimer EA; Kimura M; Cherry JD; Kuno-Sakai H; Stout MG; Dekker CL; Hayashi R; Miyamoto Y; Scott JV; Aoyama T
Am J Dis Child; 1990 Aug; 144(8):899-904. PubMed ID: 2378338
[TBL] [Abstract][Full Text] [Related]
33. Pertussis in Afghanistan, 2007-2008.
Kakar RM; Mojadidi MK; Mofleh J
Emerg Infect Dis; 2009 Mar; 15(3):501. PubMed ID: 19239779
[No Abstract] [Full Text] [Related]
34. Pertussis resurgence and vaccine uptake: implications for reducing vaccine hesitancy.
Atwell JE; Salmon DA
Pediatrics; 2014 Sep; 134(3):602-4. PubMed ID: 25136049
[No Abstract] [Full Text] [Related]
35. Persistence of antibody after accelerated immunisation with diphtheria/tetanus/pertussis vaccine.
Ramsay ME; Corbel MJ; Redhead K; Ashworth LA; Begg NT
BMJ; 1991 Jun; 302(6791):1489-91. PubMed ID: 1855015
[TBL] [Abstract][Full Text] [Related]
36. Combined, reduced-antigen content tetanus, diphtheria, and acellular pertussis vaccine (Boostrix): a review of its use as a single-dose booster immunization in individuals aged 10-64 years in the US.
Plosker GL
BioDrugs; 2009; 23(4):253-67. PubMed ID: 19697967
[TBL] [Abstract][Full Text] [Related]
37. Age at pertussis immunization as it relates to current epidemiology and disease control.
Funkhouser AW; Wassilak SG; Hinman AR; Orenstein WA; Mortimer EA
Tokai J Exp Clin Med; 1988; 13 Suppl():111-5. PubMed ID: 3273610
[TBL] [Abstract][Full Text] [Related]
38. [Time for booster doses against whooping cough for 10-year-old children].
Carlsson RM; Ekholm L; Gothefors L; Granström M; Trolin I; Tegnell A
Lakartidningen; 2005 Aug 29-Sep 4; 102(35):2394-8. PubMed ID: 16184889
[TBL] [Abstract][Full Text] [Related]
39. Association of childhood pertussis with receipt of 5 doses of pertussis vaccine by time since last vaccine dose, California, 2010.
Misegades LK; Winter K; Harriman K; Talarico J; Messonnier NE; Clark TA; Martin SW
JAMA; 2012 Nov; 308(20):2126-32. PubMed ID: 23188029
[TBL] [Abstract][Full Text] [Related]
40. Efficacy of acellular pertussis vaccine in young infants.
Aoyama T; Iwata T; Iwai H; Murase Y; Saito T; Akamatsu T
J Infect Dis; 1993 Feb; 167(2):483-6. PubMed ID: 8421187
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
